Pharma   40.48%
Services   32.19%
Diagnostics   8.11%
Medtech   7.21%
Generics   3.89%
Biotech   2.57%
Europe   47.09%
EM Asia   23.92%
Nordamerika   8.21%
EM Europe   6.54%
Asien   5.50%
EM Rest World   3.20%